Ovarian Cancer

Proximity to Treatment, Racial Disparities Are Seen in Ovarian Cancer Survival

February 15th 2021, 10:30pm


Patients with ovarian cancer who lived within 10 miles of Kansas’s only National Cancer Institute–designated cancer center, and those of a non-White race, were shown to have less of a survival advantage.

Dr Whitney Goldsberry on the Future of PARP Inhibitors in Ovarian Cancer

February 12th 2021, 5:00pm


Whitney Goldsberry, MD, clinician at the University of Alabama at Birmingham Hospital and fellow at the UAB Division of Gynecologic Oncology, gives her insight into the future of PARP inhibitors in ovarian cancer treatment.

Choice of Ovarian Cancer Surgery Influenced by Risk Perception

February 11th 2021, 12:00am


An investigation of 24 women from the United Kingdom’s PROTECTOR trial has revealed that their concerns toward cancer risk and menopause affect their choice of surgery as treatment for ovarian cancer.

Dr Whitney Goldsberry on Cost-Sharing Trends in PARP Inhibitors for Ovarian Cancer

February 6th 2021, 5:00am


Whitney Goldsberry, MD, fellow at the University of Alabama's Division of Gynecologic Oncology, discusses findings from her and colleagues' recent analysis of cost-sharing trends for PARP inhibitors in ovarian cancer treatment.

Laparoscopy Shown to Be Cost-effective in Evaluating Newly Diagnosed Ovarian Cancer

February 5th 2021, 1:00pm


Researchers from MD Anderson Cancer Center found that laparoscopy cost more upfront but eliminated wasteful treatment decisions.

Recent Adavosertib Results in Ovarian Cancer Could Be Sign of Things to Come

January 30th 2021, 6:00pm


Recent results with adavosertib in ovarian cancer could signal future positive results, given the number of trials using the targeted therapy with the PARP inhibitor olaparib.

Lauren M. Corduck, Founder of Oneinforty, Dies at 49; Advocated for Change in BRCA Testing Guidelines

January 20th 2021, 5:00pm


Lauren M. Corduck, who turned a diagnosis of ovarian cancer into a crusade to educate others with similar genetic mutations, died on December 24, 2020. She was 49.

Aggressive Treatment Might Benefit Older Patients With Ovarian Cancer

January 15th 2021, 10:30pm


Certain elderly women with ovarian cancer might benefit from aggressive treatment methods, a study recently published in Annals of Surgical Oncology found.

Payer Coverage Is the Key to Cost-effective Panel Testing in Gynecological Cancers

January 15th 2021, 5:00pm


Panel testing for genetic variants linked to more cancers is cost-effective than just testing or BRCA1/2 mutations, says a clinical director for a women's health company.

What Is Clinical Utility in a Tumor Biomarker Test? Former ASCO President Knows It When He Sees It

January 9th 2021, 9:15pm


Daniel F. Hayes, MD, offers definitions and an algorithm for clinicians to define clinical utility.